A brand new survey from the Alzheimer’s Affiliation finds that folks wish to know if they’re within the early levels of the illness, and are open to drug remedy.
MARY LOUISE KELLY, HOST:
Older People say they wish to know if they’re within the early levels of Alzheimer’s, and they’d fortunately take a blood take a look at to search out out. That is in response to a brand new nationwide survey by the Alzheimer’s Affiliation. NPR’s Jon Hamilton stories the outcomes present how attitudes towards the illness are altering.
JON HAMILTON, BYLINE: Traditionally, folks experiencing issues with reminiscence and considering have been hesitant to be taught the trigger. Elizabeth Edgerly is a scientific psychologist who directs group packages for the Alzheimer’s Affiliation.
ELIZABETH EDGERLY: Folks would usually say, nicely, gosh, I would not wish to know, or why would I wish to know?
HAMILTON: However Edgerly says the affiliation’s survey of 1,700 People 45 and older exhibits that is not the case.
EDGERLY: Seventy-nine p.c mentioned that they want to know if that they had Alzheimer’s earlier than the signs seem or not less than earlier than the signs have an effect on their each day actions.
HAMILTON: One cause could also be that it is now simpler to search out out. Only a few years in the past, it took a PET scan or spinal faucet to verify the presence of sticky amyloid plaques within the mind. Now a easy blood take a look at can present the reply. Edgerly says survey respondents had been keen about this method.
EDGERLY: 9 out of 10 folks mentioned, yeah, I might take a blood take a look at, and particularly if I do know that if I’ve Alzheimer’s, there’s one thing I can do about it.
HAMILTON: Like drug remedy. Most respondents mentioned they’d take a medicine to decelerate the illness, even when it had dangers. There at the moment are two medicine like that in the marketplace, and Edgerly says that provides folks one more reason to get a prognosis whereas they’re nonetheless able to making their very own choices.
EDGERLY: Now, folks can communicate for themselves. They will articulate what they’d like for his or her future. They will resolve whether or not they wish to strive remedies. It is actually a really completely different scenario.
HAMILTON: Alzheimer’s stays a formidable illness, however Dr. Nathaniel Chin, a geriatrician on the College of Wisconsin, says folks dwelling with Alzheimer’s illness are extra optimistic now that drug remedy is feasible.
NATHANIEL CHIN: Even when it would not cease the illness in its tracks, I feel it tells people who we’re making progress, and so they wish to know in the event that they doubtlessly might have this remedy or possibly the following remedy or two therapies down the highway.
HAMILTON: Chin says the survey outcomes are according to what he is seeing in his personal follow.
CHIN: I do not suppose persons are as fearful as they’ve been prior to now. I feel there is a want to only know what’s taking place to our our bodies.
HAMILTON: Chin says many docs, although, are nonetheless skeptical about drug remedy, which presents solely a modest profit. In consequence, he says, many are nonetheless reluctant to induce their sufferers to get examined.
CHIN: Some sufferers are forward of their docs on this regard. They’re enthusiastic about this. They need this info, and they’ll ask about it.
HAMILTON: Chin says he does supply blood assessments to sufferers with cognitive issues, and he expects the assessments to develop into more and more widespread. However that is more likely to carry some new challenges. For instance, many well being professionals aren’t educated to counsel individuals who have simply realized they’ve Alzheimer’s. And Chin says a optimistic take a look at lead to somebody’s medical report has the potential to jeopardize their job or medical health insurance.
CHIN: There are protections for individuals who be taught their genetic info, however as of now, there aren’t protections for people who find themselves studying if you’re cognitively unimpaired or cognitively wholesome.
HAMILTON: Chin says now that extra persons are discovering out, it is as much as teams, together with the Alzheimer’s Affiliation, to push for these protections.
Jon Hamilton, NPR Information.
Copyright © 2025 NPR. All rights reserved. Go to our web site phrases of use and permissions pages at www.npr.org for additional info.
Accuracy and availability of NPR transcripts might fluctuate. Transcript textual content could also be revised to appropriate errors or match updates to audio. Audio on npr.org could also be edited after its authentic broadcast or publication. The authoritative report of NPR’s programming is the audio report.
